The Latest Breaking News from FDA

Government initiatives to expand domestic biotech production and research and rising private investments in advancing technologies are expected to boost the industry’s prospects. While we believe biotech stocks Vertex Pharmaceuticals (VRTX) and Biogen (BIIB) could be ideal investments for the long run, fundamentally weak Timber Pharmaceuticals (TMBR) might be best…

The CDC is still citing underage consumption as a reason to restrict adult access.

The president's mass pardon does not extend to pot suppliers, and his rescheduling plans won't make marijuana a legal medicine.

The latest government study on teen vaping suggests there’s been little progress in keeping e-cigarettes out of the hands of kids

The FDA's nicotine restrictions will push consumers toward black-market suppliers, who are completely unconstrained by the FDA’s regulations.

Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.

LOS ANGELES -- Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost. They have visited other doctors, tried other solutions and are ready for what is considered a last resort.

Obstetricians, gynecologists, other medical professionals, and abortion rights advocates petitioned the U.S. Food and Drug Administration (FDA) on Tuesday to urge Danco Laboratories to seek approval of mifepristone, a pill used in terminating early pregnancies at home, for miscarriage management.

Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.

Millions of dollars raised during the ice bucket challenge craze of 2014 have been used in the development of a new FDA-approved treatment.

If you purchased cheese on a recent grocery run, here's everything you need to know to keep your kitchen safe